Cart
sales@molnova.com
GSK3a-IN-38
CAS No. 1062138-03-7
GSK3a-IN-38( —— )
Catalog No. M37037 CAS No. 1062138-03-7
GSK3a-IN-38 is a novel small molecule compound that has inhibitory effects on GSK-3a.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | In Stock |
|
| 5MG | 459 | In Stock |
|
| 10MG | 657 | In Stock |
|
| 25MG | 994 | In Stock |
|
| 50MG | 1371 | In Stock |
|
| 100MG | 1773 | In Stock |
|
| 500MG | 3537 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK3a-IN-38
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK3a-IN-38 is a novel small molecule compound that has inhibitory effects on GSK-3a.
-
DescriptionGSK3a-IN-38 is a novel small molecule compound that has inhibitory effects on GSK-3a.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1062138-03-7
-
Formula Weight308.38
-
Molecular FormulaC18H20N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C2=C(NC=3NN=C(C3C2C=4C=CN=CC4)C)CC(C)(C)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GSK-3β inhibitor 1
GSK-3β inhibitor 1 is an inhibitor of GSK-3β( IC50 of 4.9 nM) and demonstrates high antidiabetic efficacy.GSK-3β inhibitor 1(compound 3a) inhibits GSK-3β with IC50 4.19 nM.?In a cell-based assay 3a shows no significant leucocyte toxicity at 10 M and is moderately cytotoxic against A549 cells.?
-
CP21R7
A high-affinity, selective GSK3β inhibitor that activates canonical Wnt signaling.
-
ABC 1183
ABC1183 is a potent, selective, orally active GSK3α/β and CDK9 inhibitor with IC50 of 327/657 nM and 321 nM (CDK9/cyclin T1).
